Literature DB >> 11338255

[Right ventricular dilatation and intraventricular septal motion after surgical closure of atrial septal defect].

F Maatouk1, M Ben Farhat, F Betbout, H Gamra, K Ben Hamda, M Jarrar, S Hammami, F Added, N Ben Gadha, Z Dridi.   

Abstract

The persistence of right ventricular dilatation and paradoxical interventricular septal motion are two echocardiographic abnormalities rarely reported after surgical closure of atrial septal defects. The aim of this study was to identify the predictive factors of these abnormalities in the long-term and to study their functional consequences. One hundred and two patients aged 18 +/- 14 years (range 1-62 years) underwent closure of atrial septal defects. Thirty-five patients were under 10 years of age, 33 were 10 to 20 years of age and 34 were over 20. Fifty-six patients were female. The rhythm was sinus in the great majority of cases (97%). Three patients, all over 40 years of age, were in atrial fibrillation. Before surgery, right ventricular dilatation was observed in 95 patients (91.2%), paradoxical septal wall motion in 93 patients (91.2%), the ratio of pulmonary/systemic output was 2.7 +/- 0.6 (range 1.7 to 7.4) and over 2 in 90% of patients: pulmonary systolic pressure was 32.3 +/- 12 mmHg and over 40 mmHg in 18 patients (17.6%). Ninety-four patients were followed up regularly with a mean follow-up time of 5.5 +/- 3.6 years (1-14 years). The right ventricle remained dilated in 37 patients (39.4%) after surgery: the right ventricular dimension decreased from 36 +/- 1 to 27.8 +/- 6.2 mm (p = 0.001). The ratio of end diastolic right ventricular/left ventricular dimension also decreased from 1.07 +/- 0.31 to 0.56 +/- 0.12 (p = 0.0001). Multivariate analysis identified two predictive factors of persistent right ventricular dilatation: age > 40 years (p = 0.009) and a pulmonary/systemic flow ratio > 3 (p = 0.03). Interventricular septal wall motion remained paradoxical in 21 patients (22%). Multivariate analysis identified two predictive factors of persistent paradoxical septal motion: age > 40 years (p = 0.02) and systolic pulmonary pressures > 40 mmHg (p = 0.03). These abnormalities remained asymptomatic in all but two patients with persistent long-term hypertension and a residual atrial septal defect. The persistence of right ventricular dilatation and paradoxical septal motion was quite common, with older age at surgery, systolic pulmonary artery pressure > 40 mmHg and a ratio of pulmonary/systemic blood flow > 3, being predisposing factors. These abnormalities were clinically asymptomatic when isolated.

Entities:  

Mesh:

Year:  2001        PMID: 11338255

Source DB:  PubMed          Journal:  Arch Mal Coeur Vaiss        ISSN: 0003-9683


  4 in total

1.  Early and six-month assessment of bi-ventricular functions following surgical closure of atrial septal defect.

Authors:  Rajesh Vijayvergiya; Jiten Singh; Sandeep S Rana; Ranjan Shetty; Bhagwant R Mittal
Journal:  Indian Heart J       Date:  2014-11-10

2.  Noninvasive cardiac output measurement at rest and during exercise in pediatric patients after interventional or surgical atrial septal defect closure.

Authors:  Gesa Wiegand; Wolfhard Binder; Heidi Ulmer; Renate Kaulitz; Joachim Riethmueller; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2012-02-22       Impact factor: 1.655

3.  Mid-Term Outcome of Left Ventricle Reverse Remodeling After Atrial Septal Defect Closure: A Comparison Between Surgical and Device Groups.

Authors:  Muflih Albalawi; Salim Ahmad; Mohamed Al Nasef; Abdulmajeed Alotay; Najlaa Al Rajaa; Atif Alsahari; Irfan Saleem; Jassim Mohamed Abudlhamed
Journal:  Pediatr Cardiol       Date:  2022-03-24       Impact factor: 1.838

4.  Validation of intracardiac shunt using thoracic bioimpedance and inert gas rebreathing in adults before and after percutaneous closure of atrial septal defect in a cardiology research unit: study protocol.

Authors:  Laura Filaire; Aurelie Chalard; Hélène Perrault; Romain Trésorier; Jean-René Lusson; Bruno Pereira; Frederic Costes; Claire Dauphin; Ruddy Richard
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.